These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38225395)

  • 21. MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway.
    Geng H; Guan J
    Biochem Biophys Res Commun; 2017 Sep; 491(2):329-336. PubMed ID: 28733035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mangiferin Alleviates Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice through Regulating the PTEN/PI3K/Akt Signaling Pathway.
    Song Y; Liu W; Tang K; Zang J; Li D; Gao H
    J Diabetes Res; 2020; 2020():9481720. PubMed ID: 32076626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-222 inhibits cardiac fibrosis in diabetic mice heart via regulating Wnt/β-catenin-mediated endothelium to mesenchymal transition.
    Wang Z; Wang Z; Gao L; Xiao L; Yao R; Du B; Li Y; Wu L; Liang C; Huang Z; Li P; Zhang Y
    J Cell Physiol; 2020 Mar; 235(3):2149-2160. PubMed ID: 31389030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colonic PDGFRα Overexpression Accompanied Forkhead Transcription Factor FOXO3 Up-Regulation in STZ-Induced Diabetic Mice.
    Lu H; Zhang C; Song N; Lu C; Tong L; Huang X; Kim YC; Chen J; Xu W
    Cell Physiol Biochem; 2017; 43(1):158-171. PubMed ID: 28848093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-treatment with Resolvin D1 attenuates pulmonary hypertension by inhibiting endothelial-to-mesenchymal transition.
    Li X; Li H; Feng B; Chen X; Chen T; Lu J; Xie H; Su N; Chen H; Lou C; Zhuang R; Chen X; Jin S; Hao Y
    Biomed Pharmacother; 2024 Aug; 177():117023. PubMed ID: 38908199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SIRT3-AMPK signaling pathway as a protective target in endothelial dysfunction of early sepsis.
    Yu H; Liu Q; Chen G; Huang L; Luo M; Lv D; Luo S
    Int Immunopharmacol; 2022 May; 106():108600. PubMed ID: 35217431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice.
    Han YC; Tang SQ; Liu YT; Li AM; Zhan M; Yang M; Song N; Zhang W; Wu XQ; Peng CH; Zhang H; Yang S
    Cell Death Dis; 2021 Oct; 12(10):925. PubMed ID: 34628484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helix B surface peptide attenuates diabetic cardiomyopathy via AMPK-dependent autophagy.
    Lin C; Zhang M; Zhang Y; Yang K; Hu J; Si R; Zhang G; Gao B; Li X; Xu C; Li C; Hao Q; Guo W
    Biochem Biophys Res Commun; 2017 Jan; 482(4):665-671. PubMed ID: 27865838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart.
    Liang C; Gao L; Liu Y; Liu Y; Yao R; Li Y; Xiao L; Wu L; Du B; Huang Z; Zhang Y
    Life Sci; 2019 May; 224():12-22. PubMed ID: 30872181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA Gm16410 regulates PM
    Ma K; Li C; Xu J; Ren F; Xu X; Liu C; Niu B; Li F
    Ecotoxicol Environ Saf; 2020 Dec; 205():111327. PubMed ID: 32961493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
    Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
    Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA DANCR deficiency promotes high glucose-induced endothelial to mesenchymal transition in cardiac microvascular cells via the FoxO1/DDAH1/ADMA signaling pathway.
    Wu M; Li T; Li G; Niu B; Wu T; Yan L; Wang S; He S; Huang C; Tong W; Li N; Jiang J
    Eur J Pharmacol; 2023 Jul; 950():175732. PubMed ID: 37116560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NLRC5 deficiency ameliorates cardiac fibrosis in diabetic cardiomyopathy by regulating EndMT through Smad2/3 signaling pathway.
    Wang B; Wu Y; Ge Z; Zhang X; Yan Y; Xie Y
    Biochem Biophys Res Commun; 2020 Jul; 528(3):545-553. PubMed ID: 32505342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diosgenin alleviates arsenic trioxide induced cardiac fibrosis by inhibiting endothelial mesenchymal transition.
    Cui H; Xu W; Liu L; Hong Y; Lou H; Tang P; Lin Y; Xu H; Xie M; Du M; Tang X; Wang Z; Wang Q; Zhang Y
    Phytomedicine; 2024 Sep; 132():155891. PubMed ID: 39059093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition.
    Yin Y; Zhang Q; Zhao Q; Ding G; Wei C; Chang L; Li H; Bei H; Wang H; Liang J; Jia Z
    Biomed Res Int; 2019; 2019():6595437. PubMed ID: 31317035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendrobium officinale Attenuates Myocardial Fibrosis via Inhibiting EMT Signaling Pathway in HFD/STZ-Induced Diabetic Mice.
    Zeng J; Li D; Li Z; Zhang J; Zhao X
    Biol Pharm Bull; 2020; 43(5):864-872. PubMed ID: 32378562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vildagliptin improves high glucose-induced endothelial mitochondrial dysfunction via inhibiting mitochondrial fission.
    Liu H; Xiang H; Zhao S; Sang H; Lv F; Chen R; Shu Z; Chen AF; Chen S; Lu H
    J Cell Mol Med; 2019 Feb; 23(2):798-810. PubMed ID: 30444033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High glucose induced endothelial to mesenchymal transition in human umbilical vein endothelial cell.
    Yu CH; Suriguga ; Gong M; Liu WJ; Cui NX; Wang Y; Du X; Yi ZC
    Exp Mol Pathol; 2017 Jun; 102(3):377-383. PubMed ID: 28347704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.
    Jia L; Sun P; Gao H; Shen J; Gao Y; Meng C; Fu S; Yao H; Zhang G
    J Pharm Pharmacol; 2019 Jun; 71(6):1017-1028. PubMed ID: 30847938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-acetyl-seryl-aspartyl-lysyl-proline inhibits diabetes-associated kidney fibrosis and endothelial-mesenchymal transition.
    Nagai T; Kanasaki M; Srivastava SP; Nakamura Y; Ishigaki Y; Kitada M; Shi S; Kanasaki K; Koya D
    Biomed Res Int; 2014; 2014():696475. PubMed ID: 24783220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.